SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bryce D. Smith, Anthony K. Yartel, Comparison of Hepatitis C Virus Testing Strategies, American Journal of Preventive Medicine, 2014, 47, 3, 233

    CrossRef

  2. 2
    Mathew Strasser, Dushyant Singh, Interpretation of Abnormal Liver Function Tests, Hospital Medicine Clinics, 2014, 3, 1, e139

    CrossRef

  3. 3
    Kenichi Tanaka, Hideyuki Hyogo, Masafumi Ono, Hirokazu Takahashi, Yoichiro Kitajima, Naofumi Ono, Takahisa Eguchi, Kazuma Fujimoto, Kazuaki Chayama, Toshiji Saibara, Keizo Anzai, Yuichiro Eguchi, Upper limit of normal serum alanine aminotransferase levels in Japanese subjects, Hepatology Research, 2014, 44, 8
  4. 4
    Do Young Kim, In Hee Kim, Sook-Hyang Jeong, Yong Kyun Cho, Joon Hyoek Lee, Young-Joo Jin, Don Lee, Dong Jin Suh, Kwang-Hyub Han, Neung Hwa Park, Ha Yan Kang, Young Kul Jung, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Byung Seok Lee, Hyung Joon Yim, Heon Ju Lee, Soon Koo Baik, Won Young Tak, Sun Jae Lee, Woo Jin Chung, Sung-Kyu Choi, Eun-Young Cho, Jeong Heo, Dong Joon Kim, Byung-Cheol Song, Man Woo Kim, Jun Lee, Hee Bok Chae, Dae Hee Choi, Hwa Young Choi, Moran Ki, A nationwide seroepidemiology of hepatitis C virus infection in South Korea, Liver International, 2013, 33, 4
  5. 5
    Christie Y. Jeon, Christian K. Roberts, Catherine M. Crespi, Zuo-Feng Zhang, Elevated liver enzymes in individuals with undiagnosed diabetes in the U.S., Journal of Diabetes and its Complications, 2013, 27, 4, 333

    CrossRef

  6. You have free access to this content6
    Ryan W. Walker, Frank Sinatra, Jaana Hartiala, Marc Weigensberg, Donna Spruijt-Metz, Tanya L. Alderete, Michael I. Goran, Hooman Allayee, Genetic and clinical markers of elevated liver fat content in overweight and obese hispanic children, Obesity, 2013, 21, 12
  7. 7
    Amanda C. Wieland, Matthew Quallick, Aimee Truesdale, Pamela Mettler, Kiran M. Bambha, Identifying Practice Gaps to Optimize Medical Care for Patients with Nonalcoholic Fatty Liver Disease, Digestive Diseases and Sciences, 2013, 58, 10, 2809

    CrossRef

  8. 8
    Said A. Al-Busafi, Nir Hilzenrat, Mild Hypertransaminasemia in Primary Care, ISRN Hepatology, 2013, 2013, 1

    CrossRef

  9. 9
    Siddharth Verma, Donald Jensen, John Hart, Smruti R. Mohanty, Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD), Liver International, 2013, 33, 9
  10. 10
    Hyo-Young Kim, Jun-Hyung Park, Heebal Kim, Byeong-Chul Kang, Semantic networks for genome-wide CNV associated with AST and ALT in Korean cohorts, Molecular & Cellular Toxicology, 2013, 9, 2, 103

    CrossRef

  11. 11
    L. Pacifico, F. Ferraro, E. Bonci, C. Anania, S. Romaggioli, C. Chiesa, Upper limit of normal for alanine aminotransferase: Quo vadis?, Clinica Chimica Acta, 2013, 422, 29

    CrossRef

  12. 12
    Won Sohn, Dae Won Jun, Min Jung Kwak, Quehn Park, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Byung Chul Yoon, Ho Soon Choi, Upper limit of normal serum alanine and aspartate aminotransferase levels in Korea, Journal of Gastroenterology and Hepatology, 2013, 28, 3
  13. 13
    Seung Ha Park, Nae Yun Heo, Chang Hoon Kim, Ki Tae Suk, Dong Joon Kim, Heon Young Lee, Upper Reference Limits for Aminotransferase Activities and the Prevalence of Elevated Aminotransferase Activities in a Korean Population, Journal of Clinical Gastroenterology, 2013, 47, 1, 76

    CrossRef

  14. 14
    John R. Senior, The Path from Biomarker Discovery to Regulatory Qualification, 2013,

    CrossRef

  15. 15
    J R Senior, Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future, Clinical Pharmacology & Therapeutics, 2012, 92, 3, 332

    CrossRef